dormakaba Holding AG
No enriched coverage for $DRRKF in the last 7 days.
No SEC Form 4 filings for $DRRKF in the last 30 days.
See all $DRRKF insider activity →dormakaba (DOKA) stock rose 5.2% to CHF 60.8 after reporting a record adjusted EBITDA margin of 16.1% for FY2026. The company proposed acquiring the Mankel family's 47.5% stake for CHF 2.13B and a sale-and-leaseback deal for its HQ exceeding CHF 80M. The board also proposed a 3.3% dividend increase to CHF 0.95 per share.
Dormakaba reported fiscal year net sales of CHF 2.79 billion. The company's financial performance is detailed in the full report. According to Reuters, this data is relevant for investors tracking the firm's revenue trends.
dormakaba (DOKA) stock rose 5.2% to CHF 60.8 after reporting a record adjusted EBITDA margin of 16.1% for FY2026. The company proposed acquiring the Mankel family's 47.5% stake for CHF 2.13B and a sale-and-leaseback deal for its HQ exceeding CHF 80M. The board also proposed a 3.3% dividend increase to CHF 0.95 per share.
Dormakaba reported fiscal year net sales of CHF 2.79 billion. The company's financial performance is detailed in the full report. According to Reuters, this data is relevant for investors tracking the firm's revenue trends.
alphai scores every news story that mentions DRRKF with an AI model for sentiment and relevance, and aggregates insider trades from dormakaba Holding AG's SEC EDGAR Form 4 filings. Figures refresh continuously.
dormakaba (DOKA) stock rose 5.2% to CHF 60.8 after reporting a record adjusted EBITDA margin of 16.1% for FY2026. The company proposed acquiring the Mankel family's 47.5% stake for CHF 2.13B and a sale-and-leaseback deal for its HQ exceeding CHF 80M. The board also proposed a 3.3% dividend increase to CHF 0.95 per share.
2 min readDormakaba reported fiscal year net sales of CHF 2.79 billion. The company's financial performance is detailed in the full report. According to Reuters, this data is relevant for investors tracking the firm's revenue trends.
1 min read